Found 17 matching trials
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma PHASE3 This study will assess the efficacy and safety of mosunetuzumab in combinat...
Show More Status
Active Not Recruiting
Location
City of Hope Cancer Center
Learn More & Join Trial
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage PHASE3 Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type PHASE2 The purpose of this multi-center,single arm,phase Ⅱ clinical trail is to de...
Show More Status
Active Not Recruiting
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Learn More & Join Trial
Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma PHASE2 This is a multicenter, randomized, Phase 2 clinical trial designed to evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma PHASE2 Extranodal NK/T-cell lymphoma is a rare and highly aggressive subtype of no...
Show More Location
Sun Yat-sen Universitiy Cancer Center
Learn More & Join Trial
P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens PHASE2 This prospective study was conducted to evaluate the efficacy and safety pr...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL PHASE2 A multicenter, prospective trial to evaluate the efficacy and safety of Sel...
Show More Location
Multiple Locations
Learn More & Join Trial
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma NA This is an open-label, single-arm, multi-center Phase II clinical trial eva...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102) PHASE2 The current study is a phase II multi-center single arm trial to evaluate t...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma PHASE2 This is a multi-centre phase II, open-label, randomized (1:1), parallel-arm...
Show More Location
AOU Ospedali Riuniti di Ancona
Learn More & Join Trial